Tokyo Tape
Sign in
← Euglena

Half-year report · HY

2931.TEDINET S100YVGZ
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥26.5bn2026-01-01 → 2026-06-30Cons.Net sales
Revenue¥50.4bn2025-01-01 → 2025-12-31Cons.Net sales (5-year summary)
Revenue¥24.6bn2025-01-01 → 2025-06-30Cons.Net sales
Operating income¥1.9bn2026-01-01 → 2026-06-30Cons.Operating income
Operating income¥1.6bn2025-01-01 → 2025-06-30Cons.Operating income
Ordinary income¥1.7bn2026-01-01 → 2026-06-30Cons.Ordinary income
Ordinary income¥2.4bn2025-01-01 → 2025-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2025-01-01 → 2025-06-30Cons.Ordinary income
Profit before tax¥1.7bn2026-01-01 → 2026-06-30Cons.Income before income taxes
Profit before tax¥909m2025-01-01 → 2025-06-30Cons.Income before income taxes
Net income (owners)¥73m2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥805m2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥559m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income¥888m2026-01-01 → 2026-06-30Cons.Profit loss
Net income¥133m2025-01-01 → 2025-06-30Cons.Profit loss
Total assets¥69.3bnat 2026-06-30Cons.Assets
Total assets¥72.3bnat 2025-12-31Cons.Assets
Total assets¥69.1bnat 2025-06-30Cons.Total assets (5-year summary)
Total liabilities¥37.7bnat 2026-06-30Cons.Liabilities
Total liabilities¥43.8bnat 2025-12-31Cons.Liabilities
Net assets / equity¥31.6bnat 2026-06-30Cons.Net assets
Net assets / equity¥28.5bnat 2025-12-31Cons.Net assets
Net assets / equity¥31.7bnat 2025-06-30Cons.Net assets (5-year summary)
Cash and deposits¥17.2bnat 2026-06-30Cons.Cash and deposits
Cash and deposits¥21.2bnat 2025-12-31Cons.Cash and deposits
Cash & equivalents¥13.4bnat 2026-06-30Cons.Cash and cash equivalents
Cash & equivalents¥15.9bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥12.2bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥13.7bnat 2024-12-31vCons.Cash and cash equivalents
Operating cash flow¥1.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥5.2bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥674m2026-01-01 → 2026-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥585m2025-01-01 → 2025-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥514m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.9bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.4bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.2bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥0.532026-01-01 → 2026-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.92025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.12025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥0.522026-01-01 → 2026-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio47.8%at 2026-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.7%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio44.3%at 2025-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥4m
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥4m
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥805m
Biofuel Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥764m
Biofuel Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥764m
Biofuel Businessreportable segmentsegment profit2026-01-01 → 2026-06-30−¥160m
Health Care Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥24.3bn
Health Care Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥24.3bn
Health Care Businessreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥0
Health Care Businessreportable segmentsegment profit2026-01-01 → 2026-06-30¥3.0bn
Others Businessreportable segmentrevenue2026-01-01 → 2026-06-30¥1.4bn
Others Businessreportable segmentrevenue external2026-01-01 → 2026-06-30¥1.4bn
Others Businessreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥4m
Others Businessreportable segmentsegment profit2026-01-01 → 2026-06-30−¥202m
Total Of Reportable Segments And Otherssegment totalrevenue2026-01-01 → 2026-06-30¥26.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2026-01-01 → 2026-06-30¥26.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2026-01-01 → 2026-06-30¥4m
Total Of Reportable Segments And Otherssegment totalsegment profit2026-01-01 → 2026-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥8m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥8m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥790m
Biofuel Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥457m
Biofuel Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥457m
Biofuel Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥114m
Health Care Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥22.7bn
Health Care Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥22.7bn
Health Care Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥0
Health Care Businessreportable segmentsegment profit2025-01-01 → 2025-06-30¥2.8bn
Others Businessreportable segmentrevenue2025-01-01 → 2025-06-30¥1.4bn
Others Businessreportable segmentrevenue external2025-01-01 → 2025-06-30¥1.4bn
Others Businessreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥7m
Others Businessreportable segmentsegment profit2025-01-01 → 2025-06-30−¥218m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥24.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥24.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-06-30¥8m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 632
ItemContextValueUnit
Effect of exchange rate change on cash and cash equivalentsPrior1InterimDuration-26000000JPY
Effect of exchange rate change on cash and cash equivalentsInterimDuration4000000JPY
Net increase decrease in cash and cash equivalentsPrior1InterimDuration-1526000000JPY
Net increase decrease in cash and cash equivalentsInterimDuration-2494000000JPY
Cash and cash equivalentsPrior2YearInstant13731000000JPY
Cash and cash equivalentsPrior1YearInstant15903000000JPY
Cash and cash equivalentsPrior1InterimInstant12204000000JPY
Cash and cash equivalentsInterimInstant13408000000JPY
Salaries and allowances sgaPrior1InterimDuration1608000000JPY
Salaries and allowances sgaInterimDuration1542000000JPY
Advertising expenses sgaPrior1InterimDuration5247000000JPY
Advertising expenses sgaInterimDuration5918000000JPY
Research and development expenses sgaPrior1InterimDuration356000000JPY
Research and development expenses sgaInterimDuration315000000JPY
Depreciation sgaPrior1InterimDuration1006000000JPY
Depreciation sgaInterimDuration1016000000JPY
Direct salesPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember16703000000JPY
Direct salesPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Direct salesPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember－JPY
Direct salesPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember16703000000JPY
Direct salesPrior1InterimDuration_ReconcilingItemsMember－JPY
Direct salesPrior1InterimDuration16703000000JPY
DistributionPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember1939000000JPY
DistributionPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
DistributionPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember－JPY
DistributionPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember1939000000JPY
DistributionPrior1InterimDuration_ReconcilingItemsMember－JPY
DistributionPrior1InterimDuration1939000000JPY
Original equipment manufacturing material overseasPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember3993000000JPY
Original equipment manufacturing material overseasPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember－JPY
Original equipment manufacturing material overseasPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember3993000000JPY
Original equipment manufacturing material overseasPrior1InterimDuration_ReconcilingItemsMember－JPY
Original equipment manufacturing material overseasPrior1InterimDuration3993000000JPY
OthersPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember33000000JPY
OthersPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember457000000JPY
OthersPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember1425000000JPY
OthersPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember1916000000JPY
OthersPrior1InterimDuration_ReconcilingItemsMember－JPY
OthersPrior1InterimDuration1916000000JPY
Revenue from contracts with customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember22670000000JPY
Revenue from contracts with customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember457000000JPY
Revenue from contracts with customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember1425000000JPY
Revenue from contracts with customersPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember24553000000JPY
Revenue from contracts with customersPrior1InterimDuration_ReconcilingItemsMember－JPY
Revenue from contracts with customersPrior1InterimDuration24553000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember22670000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember457000000JPY
Revenues from external customersPrior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember1425000000JPY
Revenues from external customersPrior1InterimDuration_TotalOfReportableSegmentsAndOthersMember24553000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-12-31pass rounding
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsconsolidated 2026-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass